...
首页> 外文期刊>Annals of Gastroenterological Surgery >Overall survival after recurrence in stage I–III colorectal cancer patients in accordance with the recurrence organ site and pattern
【24h】

Overall survival after recurrence in stage I–III colorectal cancer patients in accordance with the recurrence organ site and pattern

机译:阶段I-III结直肠癌患者的复发后的整体存活按照复发器官网站和模式

获取原文
           

摘要

Aim This study aimed to investigate the prognosis after recurrence in patients with stage I–III colon cancer (CC) and rectal cancer (RC). Methods Cancer recurred in 116 (15.2%) out of 763 patients with stage I–III colorectal cancer. The overall survival (OS) after recurrence was evaluated based on the recurrence organs and patterns. Results The first recurrence occurred in the lungs, livers, lymph nodes, and other sites in 32, 22, 12, and 2 patients, respectively. It was localized, disseminated, and involved two or more organs in 14, 9, and 25 patients, respectively. Patients with CC had a shorter OS after recurrence as compared to those with RC ( P =?.0103). Compared to other organ metastasis, liver metastasis was associated with an earlier recurrence ( P =?.0026) and shorter OS after recurrence (hazard ratio [HR]: 2.216; 95% confidence interval [CI]: 1.052–4.459; P =?.0370). Lung metastasis was associated with a more favorable prognosis as compared to other organ recurrences (HR: 0.338; 95% CI: 0.135–0.741; P =?.0057). One-organ recurrence and oligometastasis were observed in 78.4% and 49.1% of the patients, respectively. The 5-y OS rates of patients with one-organ recurrence and oligometastasis were 47.5% and 71.7%, respectively. Invasive treatment was associated with a favorable prognosis ( P ?.0001). Conclusions Liver metastasis and dissemination were associated with a shorter OS after recurrence. Approximately 50% of the patients experienced oligometastasis, which was associated with a favorable prognosis. Hence, to improve patient prognosis it is better to perform invasive treatments when possible.
机译:目的本研究旨在探讨Ⅰ期IIII型结肠癌(CC)和直肠癌(RC)复发后的预后。方法癌症在763例I-III结直肠癌患者中再次成于116例(15.2%)。根据复发器官和模式进行复发后的总存活(OS)。结果分别在肺,肝,淋巴结和32,22,12和2名患者中发生的第一次复发。它是本地化,散发,并分别参与了14,9和25名患者的两种或更多种器官。与RC的那些相比,CC患者在复发后较短(P = 0103)。与其他器官转移相比,肝转移与早期复发(P =→0026)和复发后更短的操作系统(危险比[HR]:2.216; 95%置信区间[CI]:1.052-4.459; P =? .0370)。与其他器官复发相比(HR:0.338; 95%CI:0.135-0.741; P = 0057)相比,肺转移与更有利的预后有关在78.4%和49.1%的患者中观察到一个器官复发和寡替偶体。有一个器官复发和寡替氏菌患者的5-y OS率分别为47.5%和71.7%。侵入性治疗与良好的预后有关(P <。0001)。结论肝转移和传播在复发后与较短的操作系统相关。大约50%的患者经历了寡替体,这与良好的预后有关。因此,为了改善患者预后,最好在可能的情况下进行侵入性治疗。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号